Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2025-12-24 @ 5:49 PM
NCT ID:
NCT03177668
Eligibility Criteria:
Inclusion Criteria:
* Patient with male or female aged ≥ 20 (and aged \< 75 in Phase 1 part)
* Patients whose malignant pleural mesothelioma was histologically confirmed
* Patients who have advanced pleural mesothelioma that are refractory to existing anti-tumor drugs and who have no other standard therapies which should be prioritized
* Patients whose most recent major surgery (except exploratory thoracotomy or laparotomy) or drug or radiation therapy for malignant tumors, if any, was at least 4 weeks ago (at least 12 weeks ago for immunotherapy) at the subject enrollment
* Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 1 or less
Exclusion Criteria:
* Patients whose toxicity findings in the previous treatment (antineoplastic agents) have not been yet restored
* Patients with tumor lesions in central nervous system confirmed in MRI or CT
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT03177668
Study Brief:
Protocol Section:
NCT03177668